Different 510(k) Routes for FDA Approval – Special, Abbreviated & Traditional

16 May 2025

The US FDA remains ever vigilant about the products entering the US medical device market. Several pathways exist for manufacturers willing to market their medical devices via the pre-market submission route. One of them is 510(k) and within that we have various types.

Various 510(k) Programs

Out of them, the most popular are the three types of 510(k):

• Traditional 510(k)
• Abbreviated 510(k)
• Special 510(k)

The Traditional 510(k) Program

It is the most common pathway in 501(k) types. Manufacturers use this route to show substantial equivalence to their existing or predicate devices. This pathway is used for those original devices that have not been previously cleared and are not required to go through the PMA process. The pathway is also meant for change to a previously cleared device that has not qualified for a Special 510(k).

A Traditional 510(k) requires the most comprehensive documentation among the three types, including detailed performance data and testing results, to support substantial equivalence.
Review timelines for a Traditional 510(k) are around 90 calendar days, but can be extended based on the complexity of the submission or FDA queries.

The Abbreviated 510(k) Program

Medical device manufacturers can submit an abbreviated 510(k) whenever their submission relies on:

• Voluntary consensus standard(s)
• FDA guidance document(s)
• Demonstrating compliance with special control(s) for the type of device

The word “Abbreviated” in Abbreviated 510(k) doesn’t mean that the manufacturers would have to do less work. They would still have to provide all the required 510(k) sections. However, this can imply that they can prove enough equivalence via a standard instead of doing any additional testing. The manufacturers must provide summary reports for:

• Demonstration of compliance with special controls for the type of device
• Use of guidance documents
• Declaration of conformity to the FDA’s recognized standards

Rational for Using the Abbreviated Pathway

For manufacturers, it may be easier to prove their case against a standard instead of a predicate device. This is because some predicate devices can prove quite challenging to form a proper argument against a manufacturer’s case. The abbreviated pathway is simply more effective in such cases.

Using FDA-recognized consensus standards can reduce the need for costly and time-consuming device-specific testing.
It should be remembered that the Abbreviated Pathway 510(k)’s review period is within 90 days of submission.

Special 510(k) Program

According to the FDA,

“The intent of this guidance is to describe an optional pathway for certain well-defined device modifications where a manufacturer modifies its own legally marketed device, and design control procedures produce reliable results that can form, in addition to other 510(k) content requirements, the basis for substantial equivalence (SE).

In simpler words, the special 510(k) pathway is meant for medical devices that have

• already cleared their traditional 510(k) pathway, and
• had enough changes to get the clearance again“

This route leverages the manufacturer’s existing design control process and risk-based analysis to justify the modification, which can expedite FDA review.
Special 510(k) submissions are typically reviewed within 30 days, making it the fastest of the three pathways.

New Guidance for Special 510(k)

The updated version of Special 510(k) allows review of changes affecting the intended use of the device. It also allows reviewer of any changes impacting the intend use of the device or altering its basic scientific technology.

The new guidance is also focused on the methods employed to evaluate changes. To determine of a device should use the special 510(k) program, FDA recommends manufacturers consider:

• Is it being done to change the manufacturer’s own device? If that is not the case, then Special 510(k) won’t be used.
• Is there the need for performance data to evaluate the change? According to the FDA Special 510(k) Guidance, if manufacturers decide that a change doesn’t need further testing based on their design controls, they can submit it as a Special 510(k). However, they must clearly explain why no additional testing was needed.
• Does a well-established method exist for evaluating the change? If yes, then the device qualifies for the Special 510(k).
• Is it possible to review the data in a summary or risk-analysis format? If yes, then the device qualifies for the Special 510(k).

There are some scenarios worth mentioning where it is not appropriate to submit the Special 510(k). Examples of these scenarios include:

• Evaluation of changes involving more than three scientific disciplines, e.g. sterility, biocompatibility, electromagnetic compatibility.
• If multiple devices are present with unrelated changes (as per FDA’s guidance)
• If a recent QS inspection report identifies design control issues related to a 510(k) change, manufacturers should explain why those issues don’t affect the 510(k) and why it’s still eligible for the Special 510(k) Program.

Ultimately, the Special 510(k) program offers a streamlined route but demands a well-documented design control system, internal testing, and robust risk analysis to justify limited FDA review

Your Path to 510(k) Submission – Easier with TSQ&E

As a medical device manufacturer, the US market could provide an ample of lucrative opportunities for your products. However, it would be impossible to for you to market any of your products without fulfilling the US FDA, especially those concerned with 510(k).

At TSQ&E, our expert consultants provide impeccable services to our clients and help them become compliant with all the three 510(k) pathways, depending on their requirements. If you are a medical device manufacturer who wants to become compliant with 510(k), you can easily apply for consultation sessions with them through this form.